{"gene":"FAF2","run_date":"2026-04-28T17:46:03","timeline":{"discoveries":[{"year":2013,"finding":"UBXD8 (FAF2) association with the ER-resident rhomboid pseudoprotease UBAC2 specifically restricts trafficking of UBXD8 to lipid droplets (LDs), controlling its partitioning between ER and LDs.","method":"Co-IP, overexpression/knockdown manipulation of relative protein levels, live-cell imaging","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction identified, functional consequence (LD trafficking) validated by multiple orthogonal methods in a high-citation paper","pmids":["23297223"],"is_preprint":false},{"year":2013,"finding":"UBXD8 (FAF2)-mediated recruitment of p97/VCP to lipid droplets inhibits adipose triglyceride lipase (ATGL) activity by directly binding ATGL and promoting dissociation of its coactivator CGI-58, thereby increasing lipid droplet size.","method":"In vitro binding assay (direct binding of purified UBXD8 to ATGL), co-IP, siRNA knockdown with lipolysis phenotype readout","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1–2 — direct binding demonstrated in vitro plus functional epistasis; high-citation paper with multiple orthogonal methods","pmids":["23297223"],"is_preprint":false},{"year":2009,"finding":"UBXD8 (FAF2) migrates in the plane of the ER membrane to nascent lipid droplets during fatty acid supplementation and returns to the ER when lipid droplets regress, without involving the secretory pathway.","method":"Live-cell fluorescence imaging, dominant-negative Sar1 block, protein synthesis inhibition, EGFP-fusion trafficking assay","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — direct live-cell localization with multiple controls; high-citation paper","pmids":["19773358"],"is_preprint":false},{"year":2012,"finding":"UBXD8 (FAF2) recruits p97 to lipid droplets for the post-dislocation step of lipidated ApoB-100 degradation; depletion of UBXD8 decreases p97 recruitment to LDs and causes accumulation of ubiquitinated ApoB on the LD surface.","method":"siRNA knockdown, immunofluorescence, western blotting, co-IP (UBXD8 binds Derlin-1 and lipidated ApoB)","journal":"Molecular biology of the cell","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP plus KD phenotype; high-citation, multiple orthogonal methods","pmids":["22238364"],"is_preprint":false},{"year":2010,"finding":"UBXD8 (FAF2) acts as a sensor for unsaturated fatty acids (UFAs): unsaturated but not saturated FAs alter the structure of purified recombinant Ubxd8 (thermal stability, trypsin cleavage pattern, oligomerization), and this structural change relieves Ubxd8-mediated inhibition of diacylglycerol-to-triglyceride conversion.","method":"In vitro biochemistry with purified recombinant protein (thermal stability assay, limited trypsin proteolysis, native PAGE oligomerization), siRNA knockdown with lipid synthesis readout","journal":"Proceedings of the National Academy of Sciences of the United States of America","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified protein plus multiple structural assays plus cellular functional validation","pmids":["21115839"],"is_preprint":false},{"year":2013,"finding":"The UAS domain of UBXD8 (FAF2) mediates polymerization induced by long-chain unsaturated fatty acids; positively charged surface residues in the UAS domain are required, and charge-reversal mutations prevent UFA-induced oligomerization and abrogate cellular regulation by unsaturated FAs.","method":"In vitro polymerization assay with purified UAS domain, site-directed mutagenesis, native PAGE, cellular functional assay with mutants","journal":"Journal of lipid research","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with domain and mutagenesis, replicated cellular phenotype","pmids":["23720822"],"is_preprint":false},{"year":2013,"finding":"The p97-UBXD8 (FAF2) complex destabilizes p21, MKP-1, and SIRT1 mRNAs by promoting release of HuR from mRNPs; K29-linked ubiquitination of HuR serves as the release signal.","method":"RNA immunoprecipitation, co-IP, siRNA knockdown, mRNA stability assays, ubiquitin linkage-specific analysis","journal":"Genes & development","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP, RIP, mRNA decay assays, and ubiquitin chain analysis; multiple orthogonal methods","pmids":["23618873"],"is_preprint":false},{"year":2013,"finding":"Pathogenic UBQLN2 mutations impair its interaction with UBXD8 (FAF2), disrupting ERAD; UBQLN2 interacts with UBXD8 in vitro and in vivo and cooperates with it to transport ubiquitinated ERAD substrates.","method":"Co-IP (in vitro and in vivo), ERAD substrate accumulation assay, ALS-linked mutant UBQLN2 analysis","journal":"Journal of neurochemistry","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, co-IP interaction with functional consequence shown by mutant analysis","pmids":["24215460"],"is_preprint":false},{"year":2017,"finding":"UBXD8 (FAF2) is an essential mediator of sterol-stimulated proteasomal degradation of HMGCR; its UBX domain is required for sterol-induced dislocation of ubiquitylated HMGCR from the ER membrane.","method":"Haploid genetic screen (CRISPR/Cas9), UBXD8 knockout and rescue, UBX domain deletion mutants, HMGCR dislocation assay","journal":"Arteriosclerosis, thrombosis, and vascular biology","confidence":"High","confidence_rationale":"Tier 2 — unbiased genetic screen plus KO validation plus domain mutagenesis in multiple cell types","pmids":["28882874"],"is_preprint":false},{"year":2010,"finding":"ETEA/UBXD8 (FAF2) directly interacts with neurofibromin and negatively regulates it by promoting its ubiquitin-dependent proteolysis; purified ETEA ubiquitinates the neurofibromin GAP-related domain in vitro, and this requires the UBX domain.","method":"Proteomics (MS), co-IP, in vitro ubiquitination assay with purified protein, UBX domain deletion mutant, siRNA knockdown with Ras activity readout","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 1–2 — in vitro ubiquitination assay plus domain mutagenesis plus cellular epistasis","pmids":["20160012"],"is_preprint":false},{"year":2022,"finding":"UBXD8 (FAF2) localizes to mitochondria and locally recruits VCP/p97; it associates with mitochondrial and ER ubiquitin E3 ligases, degrades substrates in cis and in trans, and restrains apoptosis and mitophagy by targeting pro-apoptotic BH3-only proteins Noxa, Bik, and Bnip3 for degradation.","method":"Subcellular fractionation, co-IP, UBXD8 KO with apoptosis/mitophagy phenotype readouts, substrate identification by MS and western blot","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — KO with multiple phenotypic readouts, substrate identification by MS, and localization validated by fractionation","pmids":["35979733"],"is_preprint":false},{"year":2023,"finding":"The p97-UBXD8 (FAF2) complex localizes to ER-mitochondria contact sites (ERMCS) and negatively regulates their extent; loss of UBXD8 increases ERMCS in a p97 ATPase-activity-dependent manner and elevates membrane lipid saturation via SREBP1/SCD1.","method":"Proximity ligation, quantitative proteomics and lipidomics of ERMCS fractions, UBXD8 KO, p97 inhibitor, SREBP1/SCD1 epistasis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — quantitative proteomics/lipidomics plus genetic epistasis plus localization; multiple orthogonal methods","pmids":["36746962"],"is_preprint":false},{"year":2024,"finding":"The p97-UBXD8 (FAF2) complex suppresses pexophagy to maintain peroxisome abundance; loss of UBXD8 leads to increased ubiquitylation of the peroxisomal membrane protein PMP70 and peroxisome degradation via autophagy, rescued by overexpressing the deubiquitylase USP30 or depleting autophagy proteins.","method":"Quantitative proteomics, UBXD8 KO, autophagy flux assay, USP30 overexpression rescue, PMP70 ubiquitylation assay","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — multiple methods but preprint; consistent with published peer-reviewed findings","pmids":["39386596"],"is_preprint":true},{"year":2025,"finding":"The VCP-FAF2 (UBXD8) complex prevents excessive pexophagy by controlling ubiquitination of the peroxisomal membrane protein ABCD3, thereby maintaining peroxisome quality and quantity.","method":"ABCD3 ubiquitination assay, pexophagy flux assay, FAF2 KO","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2 — specific substrate identified with functional pexophagy readout; single lab","pmids":["39929145"],"is_preprint":false},{"year":2025,"finding":"FAF2 (UBXD8) requires its UBX and UAS thioredoxin-like domains for peroxisomal protein abundance and protection against saturated fatty acid-induced cellular stress; FAF2 is identified as a bifunctional regulator of peroxisomal homeostasis and SFA responses.","method":"Genome-wide CRISPR KO screen, FAF2 KO, domain deletion analysis (UBX and UAS), proteomics of peroxisomal proteins","journal":"Science advances","confidence":"Medium","confidence_rationale":"Tier 2 — unbiased screen plus domain mutagenesis plus KO phenotype; single lab","pmids":["40601736"],"is_preprint":false},{"year":2026,"finding":"FAF2 (and FAF1) are accessory adapters that boost p97-Ufd1-Npl4-mediated substrate unfolding and proteasomal degradation by positioning Ufd1 via a helix-UBX segment that tethers the UT3 ubiquitin-binding module of Ufd1 to the p97 N-domain; mutations abrogating the helix-Ufd1 interaction reduce stimulation of degradation.","method":"In vitro reconstitution of p97-Ufd1-Npl4-mediated unfolding coupled to proteasomal degradation, site-directed mutagenesis, biochemical unfolding assay","journal":"Science advances","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with purified components, mutagenesis, and mechanistic dissection of the helix-Ufd1 interaction","pmids":["41790892"],"is_preprint":false},{"year":2017,"finding":"UBXD8 (FAF2) promotes mitochondrial fission by mediating DRP1 translocation to mitochondria; arsenic-induced upregulation of UBXD8 increases DRP1 phosphorylation and mitochondrial over-fission leading to apoptosis.","method":"siRNA knockdown of UBXD8, DRP1 translocation assay (fractionation/immunofluorescence), mitochondrial morphology assay, Mdivi-1 inhibitor rescue","journal":"Molecular neurobiology","confidence":"Medium","confidence_rationale":"Tier 2 — KD with mechanistic readout (DRP1 translocation), but single lab and toxicological context","pmids":["39570499"],"is_preprint":false},{"year":2025,"finding":"Polyserine-targeted FAF2/UBXD8 suppresses tau aggregation independent of VCP but requiring ubiquitination, membrane localization, and its UBX domain; delivery of targeted FAF2/UBXD8 reduces insoluble tau and gliosis in PS19 tau transgenic mice.","method":"Polyserine targeting in cell-based tau aggregation assays, domain deletion mutants (UBX, membrane-targeting), Drosophila tau neurodegeneration model, PS19 mouse model (behavioral and biochemical readouts)","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1–2 — domain mutagenesis, in vivo animal validation in two model organisms, multiple orthogonal readouts","pmids":["40902597"],"is_preprint":false},{"year":2002,"finding":"ETEA (FAF2) protein interacts with the Fas death domain, albeit more weakly than FAF1, and is expressed in the cytoplasm; the ETEA-EGFP fusion protein localizes to the cytoplasm.","method":"Yeast two-hybrid, EGFP fusion localization","journal":"Biochemical and biophysical research communications","confidence":"Low","confidence_rationale":"Tier 3 — yeast two-hybrid and single localization experiment; no rigorous mechanistic follow-up","pmids":["12372427"],"is_preprint":false}],"current_model":"FAF2/UBXD8 is a multi-domain (UBA, UAS, UBX) membrane-embedded adaptor protein that recruits the AAA-ATPase p97/VCP to the ER, lipid droplets, mitochondria, and ER-mitochondria contact sites to drive ubiquitin-dependent substrate extraction and proteasomal degradation (ERAD substrates, HMGCR, ApoB, Noxa, Bnip3); its UAS domain acts as a direct sensor for long-chain unsaturated fatty acids that induce oligomerization and relieve inhibition of triglyceride synthesis; and its UBX domain, together with a helix segment that positions Ufd1 on p97, is required for stimulating p97-mediated substrate unfolding, proteasomal degradation, peroxisome quality control via suppression of pexophagy, mRNP disassembly, and neurofibromin ubiquitination."},"narrative":{"teleology":[{"year":2002,"claim":"Initial identification of FAF2 (ETEA) as a Fas-associated protein established it as a potential component of death-receptor signaling, though its functional role remained unclear.","evidence":"Yeast two-hybrid screen identifying interaction with the Fas death domain; EGFP fusion localization","pmids":["12372427"],"confidence":"Low","gaps":["Interaction with Fas not validated by reciprocal co-IP or in vitro binding","No functional consequence of the Fas interaction demonstrated","Cytoplasmic localization does not resolve membrane association"]},{"year":2009,"claim":"Demonstration that FAF2 dynamically shuttles between the ER and nascent lipid droplets via lateral membrane diffusion established its dual-organelle residency and linked it to lipid droplet biogenesis.","evidence":"Live-cell fluorescence imaging with EGFP-FAF2, dominant-negative Sar1, protein synthesis inhibition in mammalian cells","pmids":["19773358"],"confidence":"High","gaps":["Membrane anchor topology not fully resolved","Signal triggering ER-to-LD migration not identified at the molecular level"]},{"year":2010,"claim":"Two studies revealed FAF2's dual biochemical activities: direct sensing of unsaturated fatty acids via conformational change and oligomerization that controls triglyceride synthesis, and UBX-domain-dependent ubiquitination and degradation of neurofibromin, establishing FAF2 as both a lipid sensor and a p97-dependent degradation adaptor.","evidence":"In vitro reconstitution with purified recombinant FAF2 (thermal stability, limited proteolysis, native PAGE oligomerization) plus siRNA knockdown for lipid synthesis; proteomics-identified neurofibromin interaction, in vitro ubiquitination assay, domain mutants with Ras activity readout","pmids":["21115839","20160012"],"confidence":"High","gaps":["Identity of the fatty acid binding site within the UAS domain not structurally resolved","Whether neurofibromin ubiquitination is a direct E3 activity or requires a recruited E3 ligase"]},{"year":2012,"claim":"Showing that FAF2 recruits p97 to lipid droplets for post-dislocation degradation of lipidated ApoB-100 defined it as the critical LD-localized adaptor for ERAD-like substrate processing outside the ER.","evidence":"siRNA knockdown of UBXD8, co-IP with Derlin-1 and ApoB, immunofluorescence of p97 recruitment to LDs","pmids":["22238364"],"confidence":"High","gaps":["Whether other UBX-domain proteins can substitute for FAF2 on LDs","Structural basis of FAF2-Derlin-1 interaction unknown"]},{"year":2013,"claim":"Multiple 2013 studies expanded FAF2's mechanistic repertoire: (1) UBAC2 was identified as an ER-resident factor restricting FAF2 LD trafficking; (2) FAF2 was shown to inhibit ATGL lipolysis by direct binding and CGI-58 displacement on LDs; (3) the UAS domain's positively charged surface was mapped as the UFA-sensing oligomerization interface; (4) the p97-FAF2 complex was linked to mRNP remodeling via K29-ubiquitin-dependent HuR release.","evidence":"Co-IP and live-cell imaging for UBAC2 interaction; in vitro binding assay of purified FAF2 to ATGL; UAS domain mutagenesis with native PAGE; RNA immunoprecipitation and ubiquitin linkage analysis for HuR/mRNA regulation","pmids":["23297223","23720822","23618873"],"confidence":"High","gaps":["Structural model of UAS-UFA complex lacking","Mechanism by which K29-linked ubiquitin on HuR is generated not identified","Whether UBAC2-mediated retention is regulated by metabolic cues"]},{"year":2013,"claim":"The finding that ALS-linked UBQLN2 mutations impair interaction with FAF2 and compromise ERAD connected FAF2 to neurodegenerative disease pathology.","evidence":"Co-IP of UBQLN2 and FAF2 in vitro and in vivo; ERAD substrate accumulation with mutant UBQLN2","pmids":["24215460"],"confidence":"Medium","gaps":["UBQLN2-FAF2 interaction not validated by independent lab","Whether FAF2 loss alone phenocopies UBQLN2-mutant ERAD defects not tested","Structural basis of the UBQLN2-FAF2 interaction unknown"]},{"year":2017,"claim":"Identification of FAF2 as essential for sterol-induced HMGCR degradation via an unbiased haploid genetic screen established it as a non-redundant component of cholesterol homeostasis, with the UBX domain required for membrane dislocation.","evidence":"CRISPR/Cas9 haploid screen, UBXD8 KO and rescue, UBX domain deletion, HMGCR dislocation assay in multiple cell types","pmids":["28882874"],"confidence":"High","gaps":["Whether FAF2 directly contacts HMGCR or acts via Insig/gp78 complex","In vivo cholesterol phenotype in FAF2 knockout animals not reported"]},{"year":2022,"claim":"Discovery of FAF2 localization to mitochondria and its role in degrading pro-apoptotic BH3-only proteins (Noxa, Bik, Bnip3) revealed it as a mitochondrial quality-control factor restraining apoptosis and mitophagy.","evidence":"Subcellular fractionation, co-IP with mitochondrial E3 ligases, UBXD8 KO with apoptosis and mitophagy phenotype, substrate ID by mass spectrometry","pmids":["35979733"],"confidence":"High","gaps":["How FAF2 is targeted to OMM versus ER versus LDs not resolved","Which mitochondrial E3 ligase is the primary partner"]},{"year":2023,"claim":"Localization of the p97-FAF2 complex to ER-mitochondria contact sites and demonstration that its loss increases ERMCS extent and elevates membrane lipid saturation via SREBP1/SCD1 identified FAF2 as a regulator of inter-organelle contact site homeostasis and lipid composition.","evidence":"Proximity ligation, quantitative proteomics and lipidomics of ERMCS fractions, UBXD8 KO, p97 inhibitor, SREBP1/SCD1 epistasis","pmids":["36746962"],"confidence":"High","gaps":["Specific ERMCS substrate(s) extracted by p97-FAF2 not identified","Whether ERMCS regulation is direct or secondary to lipid composition changes"]},{"year":2025,"claim":"Two studies established FAF2 as a suppressor of pexophagy by controlling ubiquitination of peroxisomal membrane proteins (PMP70/ABCD3), with UBX and UAS domains required for peroxisome homeostasis and protection against saturated fatty acid stress.","evidence":"Quantitative proteomics, FAF2 KO, pexophagy flux assay, ABCD3 ubiquitination assay, USP30 rescue, genome-wide CRISPR screen, domain deletion analysis","pmids":["39929145","40601736"],"confidence":"Medium","gaps":["Which E3 ligase ubiquitinates ABCD3 under FAF2 control not identified","Whether FAF2 localizes to peroxisomes directly or acts from ER","Independent replication of peroxisome phenotype by additional labs needed"]},{"year":2025,"claim":"Engineering polyserine-targeted FAF2 to suppress tau aggregation in cell, fly, and mouse models demonstrated that FAF2's ubiquitin-dependent degradation machinery can be redirected to pathological protein aggregates, establishing therapeutic proof-of-concept.","evidence":"Polyserine targeting in tau aggregation assays, domain deletion mutants, Drosophila neurodegeneration model, PS19 mouse model with behavioral and biochemical readouts","pmids":["40902597"],"confidence":"High","gaps":["Whether endogenous FAF2 engages tau in unmodified settings unknown","Long-term safety and off-target degradation not assessed","Mechanism by which membrane-localized FAF2 accesses cytoplasmic tau aggregates unclear"]},{"year":2026,"claim":"In vitro reconstitution revealed that FAF2 stimulates p97-Ufd1-Npl4-mediated substrate unfolding and proteasomal degradation by positioning Ufd1's UT3 ubiquitin-binding module on the p97 N-domain via a helix-UBX segment, resolving the long-standing question of how UBX-domain cofactors enhance p97 processivity.","evidence":"In vitro reconstitution of p97-mediated unfolding coupled to proteasomal degradation with purified components; site-directed mutagenesis of helix-Ufd1 interface","pmids":["41790892"],"confidence":"High","gaps":["Whether the helix-UBX mechanism is shared by FAF1 in vivo","Structural resolution of the ternary FAF2-Ufd1-p97 complex lacking","Contribution of UBA domain to substrate selection during unfolding not tested"]},{"year":null,"claim":"Major open questions include: the structural basis for UAS domain fatty acid sensing and oligomerization; how FAF2 is differentially targeted to ER, lipid droplets, mitochondria, ERMCS, and peroxisomes; and whether FAF2 loss in vivo causes metabolic or neurological disease in mammals.","evidence":"","pmids":[],"confidence":"Low","gaps":["No high-resolution structure of full-length FAF2 or the UAS-UFA complex","No animal knockout phenotype systematically characterized","Mechanisms governing organelle-specific targeting of a single membrane-embedded adaptor unresolved"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[1,3,6,8,10,11,12,13,15]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[4,5]},{"term_id":"GO:0140299","term_label":"molecular sensor activity","supporting_discovery_ids":[4,5]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[1,9,15]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[0,2,8]},{"term_id":"GO:0005811","term_label":"lipid droplet","supporting_discovery_ids":[1,2,3]},{"term_id":"GO:0005739","term_label":"mitochondrion","supporting_discovery_ids":[10,16]},{"term_id":"GO:0005777","term_label":"peroxisome","supporting_discovery_ids":[12,13,14]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[3,8,9,10,15]},{"term_id":"R-HSA-1430728","term_label":"Metabolism","supporting_discovery_ids":[1,4,5,8,11]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[12,13]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[10]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[6]}],"complexes":["p97/VCP-Ufd1-Npl4 complex"],"partners":["VCP","UFD1","UBAC2","ATGL","UBQLN2","NF1","ELAVL1","DRP1"],"other_free_text":[]},"mechanistic_narrative":"FAF2/UBXD8 is a membrane-embedded, multi-domain adaptor protein that recruits the AAA-ATPase p97/VCP to the ER, lipid droplets, mitochondria, ER-mitochondria contact sites, and peroxisomes, coupling ubiquitin-dependent substrate extraction to proteasomal degradation across multiple organellar quality-control pathways. Its UBA, UAS, and UBX domains enable recognition of ubiquitinated substrates and p97 engagement: the UAS domain directly senses long-chain unsaturated fatty acids, which induce its oligomerization and relieve FAF2-mediated inhibition of triglyceride synthesis, while a helix-UBX segment positions the Ufd1 cofactor on p97 to stimulate substrate unfolding and degradation [PMID:21115839, PMID:23720822, PMID:41790892]. FAF2 mediates sterol-induced HMGCR dislocation, lipidated ApoB-100 turnover on lipid droplets, degradation of pro-apoptotic BH3-only proteins at mitochondria, control of ER-mitochondria contact site extent via SREBP1/SCD1, suppression of pexophagy through regulation of peroxisomal membrane protein ubiquitination, and HuR release from mRNPs leading to mRNA destabilization [PMID:28882874, PMID:22238364, PMID:35979733, PMID:36746962, PMID:39929145, PMID:23618873]. On lipid droplets, FAF2 additionally inhibits ATGL-mediated lipolysis by directly binding ATGL and dissociating its coactivator CGI-58, with its ER-to-LD trafficking regulated by the rhomboid pseudoprotease UBAC2 [PMID:23297223]."},"prefetch_data":{"uniprot":{"accession":"Q96CS3","full_name":"FAS-associated factor 2","aliases":["UBX domain-containing protein 3B","UBX domain-containing protein 8"],"length_aa":445,"mass_kda":52.6,"function":"Plays an important role in endoplasmic reticulum-associated degradation (ERAD) that mediates ubiquitin-dependent degradation of misfolded endoplasmic reticulum proteins (PubMed:18711132, PubMed:24215460). By controlling the steady-state expression of the IGF1R receptor, indirectly regulates the insulin-like growth factor receptor signaling pathway (PubMed:26692333). Involved in inhibition of lipid droplet degradation by binding to phospholipase PNPL2 and inhibiting its activity by promoting dissociation of PNPL2 from its endogenous activator, ABHD5 which inhibits the rate of triacylglycerol hydrolysis (PubMed:23297223). Involved in stress granule disassembly: associates with ubiquitinated G3BP1 in response to heat shock, thereby promoting interaction between ubiquitinated G3BP1 and VCP, followed by G3BP1 extraction from stress granules and stress granule disassembly (PubMed:34739333)","subcellular_location":"Cytoplasm; Lipid droplet; Endoplasmic reticulum","url":"https://www.uniprot.org/uniprotkb/Q96CS3/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/FAF2","classification":"Common Essential","n_dependent_lines":765,"n_total_lines":1208,"dependency_fraction":0.6332781456953642},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"ANKRD46","stoichiometry":0.2},{"gene":"CANX","stoichiometry":0.2},{"gene":"TMED10","stoichiometry":0.2},{"gene":"VCP","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/FAF2","total_profiled":1310},"omim":[{"mim_id":"616935","title":"FAS-ASSOCIATED FACTOR FAMILY, MEMBER 2; FAF2","url":"https://www.omim.org/entry/616935"},{"mim_id":"616175","title":"UBIQUITIN-CONJUGATING ENZYME E2 J1; UBE2J1","url":"https://www.omim.org/entry/616175"},{"mim_id":"613113","title":"NEUROFIBROMIN 1; NF1","url":"https://www.omim.org/entry/613113"},{"mim_id":"610304","title":"DER1-LIKE DOMAIN FAMILY, MEMBER 2; DERL2","url":"https://www.omim.org/entry/610304"},{"mim_id":"609677","title":"OS9 ENDOPLASMIC RETICULUM LECTIN; OS9","url":"https://www.omim.org/entry/609677"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Enhanced","locations":[{"location":"Lipid droplets","reliability":"Enhanced"},{"location":"Endoplasmic reticulum","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/FAF2"},"hgnc":{"alias_symbol":["ETEA","KIAA0887","UBXN3B"],"prev_symbol":["UBXD8"]},"alphafold":{"accession":"Q96CS3","domains":[{"cath_id":"3.40.30.10","chopping":"78-279","consensus_level":"high","plddt":87.3598,"start":78,"end":279},{"cath_id":"3.10.20.90","chopping":"360-440","consensus_level":"high","plddt":86.6958,"start":360,"end":440}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96CS3","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q96CS3-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q96CS3-F1-predicted_aligned_error_v6.png","plddt_mean":85.31},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=FAF2","jax_strain_url":"https://www.jax.org/strain/search?query=FAF2"},"sequence":{"accession":"Q96CS3","fasta_url":"https://rest.uniprot.org/uniprotkb/Q96CS3.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q96CS3/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q96CS3"}},"corpus_meta":[{"pmid":"23297223","id":"PMC_23297223","title":"Spatial regulation of UBXD8 and p97/VCP controls ATGL-mediated lipid droplet turnover.","date":"2013","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/23297223","citation_count":193,"is_preprint":false},{"pmid":"19773358","id":"PMC_19773358","title":"Targeting sequences of UBXD8 and AAM-B reveal that the ER has a direct role in the emergence and regression of lipid droplets.","date":"2009","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/19773358","citation_count":109,"is_preprint":false},{"pmid":"22238364","id":"PMC_22238364","title":"Derlin-1 and UBXD8 are engaged in dislocation and degradation of lipidated ApoB-100 at lipid droplets.","date":"2012","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/22238364","citation_count":95,"is_preprint":false},{"pmid":"21115839","id":"PMC_21115839","title":"Identification of Ubxd8 protein as a sensor for unsaturated fatty acids and regulator of triglyceride synthesis.","date":"2010","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/21115839","citation_count":87,"is_preprint":false},{"pmid":"22454508","id":"PMC_22454508","title":"The ubiquitin-like (UBX)-domain-containing protein Ubx2/Ubxd8 regulates lipid droplet homeostasis.","date":"2012","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/22454508","citation_count":71,"is_preprint":false},{"pmid":"29899553","id":"PMC_29899553","title":"UBXN3B positively regulates STING-mediated antiviral immune responses.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29899553","citation_count":63,"is_preprint":false},{"pmid":"24215460","id":"PMC_24215460","title":"Pathogenic mutation of UBQLN2 impairs its interaction with UBXD8 and disrupts endoplasmic reticulum-associated protein degradation.","date":"2013","source":"Journal of neurochemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24215460","citation_count":60,"is_preprint":false},{"pmid":"23618873","id":"PMC_23618873","title":"The p97-UBXD8 complex destabilizes mRNA by promoting release of ubiquitinated HuR from mRNP.","date":"2013","source":"Genes & development","url":"https://pubmed.ncbi.nlm.nih.gov/23618873","citation_count":58,"is_preprint":false},{"pmid":"35979733","id":"PMC_35979733","title":"UBXD8 mediates mitochondria-associated degradation to restrain apoptosis and mitophagy.","date":"2022","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/35979733","citation_count":43,"is_preprint":false},{"pmid":"20160012","id":"PMC_20160012","title":"The RasGAP proteins Ira2 and neurofibromin are negatively regulated by Gpb1 in yeast and ETEA in humans.","date":"2010","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/20160012","citation_count":42,"is_preprint":false},{"pmid":"23720822","id":"PMC_23720822","title":"UAS domain of Ubxd8 and FAF1 polymerizes upon interaction with long-chain unsaturated fatty acids.","date":"2013","source":"Journal of lipid research","url":"https://pubmed.ncbi.nlm.nih.gov/23720822","citation_count":38,"is_preprint":false},{"pmid":"36746962","id":"PMC_36746962","title":"The p97-UBXD8 complex regulates ER-Mitochondria contact sites by altering membrane lipid saturation and composition.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/36746962","citation_count":34,"is_preprint":false},{"pmid":"28882874","id":"PMC_28882874","title":"Haploid Mammalian Genetic Screen Identifies UBXD8 as a Key Determinant of HMGCR Degradation and Cholesterol Biosynthesis.","date":"2017","source":"Arteriosclerosis, thrombosis, and vascular biology","url":"https://pubmed.ncbi.nlm.nih.gov/28882874","citation_count":29,"is_preprint":false},{"pmid":"25970332","id":"PMC_25970332","title":"Hepatocyte-Specific Depletion of UBXD8 Induces Periportal Steatosis in Mice Fed a High-Fat Diet.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25970332","citation_count":16,"is_preprint":false},{"pmid":"12372427","id":"PMC_12372427","title":"Cloning and characterization of the highly expressed ETEA gene from blood cells of atopic dermatitis patients.","date":"2002","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/12372427","citation_count":15,"is_preprint":false},{"pmid":"39969435","id":"PMC_39969435","title":"Silencing FAF2 mitigates alcohol-induced hepatic steatosis by modulating lipolysis and PCSK9 pathway.","date":"2025","source":"Hepatology communications","url":"https://pubmed.ncbi.nlm.nih.gov/39969435","citation_count":6,"is_preprint":false},{"pmid":"39570499","id":"PMC_39570499","title":"Neurotoxicity of Realgar: Crosstalk Between UBXD8-DRP1-Regulated Mitochondrial Fission and PINK1-Parkin-Mediated Mitophagy.","date":"2024","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/39570499","citation_count":5,"is_preprint":false},{"pmid":"40902597","id":"PMC_40902597","title":"Polyserine-mediated targeting of FAF2/UBXD8 ameliorates tau aggregation.","date":"2025","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/40902597","citation_count":3,"is_preprint":false},{"pmid":"40601736","id":"PMC_40601736","title":"FAF2 is a bifunctional regulator of peroxisomal homeostasis and saturated lipid responses.","date":"2025","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/40601736","citation_count":2,"is_preprint":false},{"pmid":"36377866","id":"PMC_36377866","title":"UBXN3B Controls Immunopathogenesis of Arthritogenic Alphaviruses by Maintaining Hematopoietic Homeostasis.","date":"2022","source":"mBio","url":"https://pubmed.ncbi.nlm.nih.gov/36377866","citation_count":2,"is_preprint":false},{"pmid":"39763943","id":"PMC_39763943","title":"FAF2 is a bifunctional regulator of peroxisomal homeostasis and saturated lipid responses.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39763943","citation_count":1,"is_preprint":false},{"pmid":"39018756","id":"PMC_39018756","title":"UBXN3B is crucial for B lymphopoiesis.","date":"2024","source":"EBioMedicine","url":"https://pubmed.ncbi.nlm.nih.gov/39018756","citation_count":1,"is_preprint":false},{"pmid":"39386596","id":"PMC_39386596","title":"The p97-UBXD8 complex maintains peroxisome abundance by suppressing pexophagy.","date":"2024","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/39386596","citation_count":1,"is_preprint":false},{"pmid":"39929145","id":"PMC_39929145","title":"Quality control of ABCD3 by the VCP-FAF2 complex suppresses excessive pexophagy.","date":"2025","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/39929145","citation_count":1,"is_preprint":false},{"pmid":"38181884","id":"PMC_38181884","title":"Sensing and regulation of long-chain polyunsaturated fatty acids pool in marine mollusks: Characterization of UBXD8 from the razor clam Sinonovacula constricta.","date":"2024","source":"Biochimica et biophysica acta. Molecular and cell biology of lipids","url":"https://pubmed.ncbi.nlm.nih.gov/38181884","citation_count":1,"is_preprint":false},{"pmid":"40562127","id":"PMC_40562127","title":"UBXD8 promotes lung cancer progression and activates the HIF-1α pathway.","date":"2025","source":"Biochemical pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/40562127","citation_count":0,"is_preprint":false},{"pmid":"34462748","id":"PMC_34462748","title":"An Essential Role of UBXN3B in B Lymphopoiesis.","date":"2021","source":"bioRxiv : the preprint server for biology","url":"https://pubmed.ncbi.nlm.nih.gov/34462748","citation_count":0,"is_preprint":false},{"pmid":"41790892","id":"PMC_41790892","title":"The accessory adapters FAF1, FAF2, and UBXN7 accelerate proteasomal degradation by increasing prior p97-mediated substrate unfolding.","date":"2026","source":"Science advances","url":"https://pubmed.ncbi.nlm.nih.gov/41790892","citation_count":0,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2024.05.15.594178","title":"The balance between antiviral and antibacterial responses during<i>M. tuberculosis</i>infection is regulated by the ubiquitin ligase CBL","date":"2024-05-18","source":"bioRxiv","url":"https://doi.org/10.1101/2024.05.15.594178","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.25.24317794","title":"Multi-ancestry genome-wide association study reveals novel genetic signals for lung function decline","date":"2024-11-27","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.25.24317794","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":15697,"output_tokens":4435,"usd":0.056808},"stage2":{"model":"claude-opus-4-6","input_tokens":7909,"output_tokens":3831,"usd":0.20298},"total_usd":0.259788,"stage1_batch_id":"msgbatch_0118RScg3WGaGkaZRtWZbtce","stage2_batch_id":"msgbatch_01Cpfzvtbj42aqp5oYZ5Te2s","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2013,\n      \"finding\": \"UBXD8 (FAF2) association with the ER-resident rhomboid pseudoprotease UBAC2 specifically restricts trafficking of UBXD8 to lipid droplets (LDs), controlling its partitioning between ER and LDs.\",\n      \"method\": \"Co-IP, overexpression/knockdown manipulation of relative protein levels, live-cell imaging\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction identified, functional consequence (LD trafficking) validated by multiple orthogonal methods in a high-citation paper\",\n      \"pmids\": [\"23297223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"UBXD8 (FAF2)-mediated recruitment of p97/VCP to lipid droplets inhibits adipose triglyceride lipase (ATGL) activity by directly binding ATGL and promoting dissociation of its coactivator CGI-58, thereby increasing lipid droplet size.\",\n      \"method\": \"In vitro binding assay (direct binding of purified UBXD8 to ATGL), co-IP, siRNA knockdown with lipolysis phenotype readout\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — direct binding demonstrated in vitro plus functional epistasis; high-citation paper with multiple orthogonal methods\",\n      \"pmids\": [\"23297223\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"UBXD8 (FAF2) migrates in the plane of the ER membrane to nascent lipid droplets during fatty acid supplementation and returns to the ER when lipid droplets regress, without involving the secretory pathway.\",\n      \"method\": \"Live-cell fluorescence imaging, dominant-negative Sar1 block, protein synthesis inhibition, EGFP-fusion trafficking assay\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct live-cell localization with multiple controls; high-citation paper\",\n      \"pmids\": [\"19773358\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"UBXD8 (FAF2) recruits p97 to lipid droplets for the post-dislocation step of lipidated ApoB-100 degradation; depletion of UBXD8 decreases p97 recruitment to LDs and causes accumulation of ubiquitinated ApoB on the LD surface.\",\n      \"method\": \"siRNA knockdown, immunofluorescence, western blotting, co-IP (UBXD8 binds Derlin-1 and lipidated ApoB)\",\n      \"journal\": \"Molecular biology of the cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP plus KD phenotype; high-citation, multiple orthogonal methods\",\n      \"pmids\": [\"22238364\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"UBXD8 (FAF2) acts as a sensor for unsaturated fatty acids (UFAs): unsaturated but not saturated FAs alter the structure of purified recombinant Ubxd8 (thermal stability, trypsin cleavage pattern, oligomerization), and this structural change relieves Ubxd8-mediated inhibition of diacylglycerol-to-triglyceride conversion.\",\n      \"method\": \"In vitro biochemistry with purified recombinant protein (thermal stability assay, limited trypsin proteolysis, native PAGE oligomerization), siRNA knockdown with lipid synthesis readout\",\n      \"journal\": \"Proceedings of the National Academy of Sciences of the United States of America\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified protein plus multiple structural assays plus cellular functional validation\",\n      \"pmids\": [\"21115839\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The UAS domain of UBXD8 (FAF2) mediates polymerization induced by long-chain unsaturated fatty acids; positively charged surface residues in the UAS domain are required, and charge-reversal mutations prevent UFA-induced oligomerization and abrogate cellular regulation by unsaturated FAs.\",\n      \"method\": \"In vitro polymerization assay with purified UAS domain, site-directed mutagenesis, native PAGE, cellular functional assay with mutants\",\n      \"journal\": \"Journal of lipid research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with domain and mutagenesis, replicated cellular phenotype\",\n      \"pmids\": [\"23720822\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"The p97-UBXD8 (FAF2) complex destabilizes p21, MKP-1, and SIRT1 mRNAs by promoting release of HuR from mRNPs; K29-linked ubiquitination of HuR serves as the release signal.\",\n      \"method\": \"RNA immunoprecipitation, co-IP, siRNA knockdown, mRNA stability assays, ubiquitin linkage-specific analysis\",\n      \"journal\": \"Genes & development\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP, RIP, mRNA decay assays, and ubiquitin chain analysis; multiple orthogonal methods\",\n      \"pmids\": [\"23618873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Pathogenic UBQLN2 mutations impair its interaction with UBXD8 (FAF2), disrupting ERAD; UBQLN2 interacts with UBXD8 in vitro and in vivo and cooperates with it to transport ubiquitinated ERAD substrates.\",\n      \"method\": \"Co-IP (in vitro and in vivo), ERAD substrate accumulation assay, ALS-linked mutant UBQLN2 analysis\",\n      \"journal\": \"Journal of neurochemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, co-IP interaction with functional consequence shown by mutant analysis\",\n      \"pmids\": [\"24215460\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"UBXD8 (FAF2) is an essential mediator of sterol-stimulated proteasomal degradation of HMGCR; its UBX domain is required for sterol-induced dislocation of ubiquitylated HMGCR from the ER membrane.\",\n      \"method\": \"Haploid genetic screen (CRISPR/Cas9), UBXD8 knockout and rescue, UBX domain deletion mutants, HMGCR dislocation assay\",\n      \"journal\": \"Arteriosclerosis, thrombosis, and vascular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — unbiased genetic screen plus KO validation plus domain mutagenesis in multiple cell types\",\n      \"pmids\": [\"28882874\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"ETEA/UBXD8 (FAF2) directly interacts with neurofibromin and negatively regulates it by promoting its ubiquitin-dependent proteolysis; purified ETEA ubiquitinates the neurofibromin GAP-related domain in vitro, and this requires the UBX domain.\",\n      \"method\": \"Proteomics (MS), co-IP, in vitro ubiquitination assay with purified protein, UBX domain deletion mutant, siRNA knockdown with Ras activity readout\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — in vitro ubiquitination assay plus domain mutagenesis plus cellular epistasis\",\n      \"pmids\": [\"20160012\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"UBXD8 (FAF2) localizes to mitochondria and locally recruits VCP/p97; it associates with mitochondrial and ER ubiquitin E3 ligases, degrades substrates in cis and in trans, and restrains apoptosis and mitophagy by targeting pro-apoptotic BH3-only proteins Noxa, Bik, and Bnip3 for degradation.\",\n      \"method\": \"Subcellular fractionation, co-IP, UBXD8 KO with apoptosis/mitophagy phenotype readouts, substrate identification by MS and western blot\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — KO with multiple phenotypic readouts, substrate identification by MS, and localization validated by fractionation\",\n      \"pmids\": [\"35979733\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2023,\n      \"finding\": \"The p97-UBXD8 (FAF2) complex localizes to ER-mitochondria contact sites (ERMCS) and negatively regulates their extent; loss of UBXD8 increases ERMCS in a p97 ATPase-activity-dependent manner and elevates membrane lipid saturation via SREBP1/SCD1.\",\n      \"method\": \"Proximity ligation, quantitative proteomics and lipidomics of ERMCS fractions, UBXD8 KO, p97 inhibitor, SREBP1/SCD1 epistasis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — quantitative proteomics/lipidomics plus genetic epistasis plus localization; multiple orthogonal methods\",\n      \"pmids\": [\"36746962\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"The p97-UBXD8 (FAF2) complex suppresses pexophagy to maintain peroxisome abundance; loss of UBXD8 leads to increased ubiquitylation of the peroxisomal membrane protein PMP70 and peroxisome degradation via autophagy, rescued by overexpressing the deubiquitylase USP30 or depleting autophagy proteins.\",\n      \"method\": \"Quantitative proteomics, UBXD8 KO, autophagy flux assay, USP30 overexpression rescue, PMP70 ubiquitylation assay\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple methods but preprint; consistent with published peer-reviewed findings\",\n      \"pmids\": [\"39386596\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"The VCP-FAF2 (UBXD8) complex prevents excessive pexophagy by controlling ubiquitination of the peroxisomal membrane protein ABCD3, thereby maintaining peroxisome quality and quantity.\",\n      \"method\": \"ABCD3 ubiquitination assay, pexophagy flux assay, FAF2 KO\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — specific substrate identified with functional pexophagy readout; single lab\",\n      \"pmids\": [\"39929145\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"FAF2 (UBXD8) requires its UBX and UAS thioredoxin-like domains for peroxisomal protein abundance and protection against saturated fatty acid-induced cellular stress; FAF2 is identified as a bifunctional regulator of peroxisomal homeostasis and SFA responses.\",\n      \"method\": \"Genome-wide CRISPR KO screen, FAF2 KO, domain deletion analysis (UBX and UAS), proteomics of peroxisomal proteins\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — unbiased screen plus domain mutagenesis plus KO phenotype; single lab\",\n      \"pmids\": [\"40601736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2026,\n      \"finding\": \"FAF2 (and FAF1) are accessory adapters that boost p97-Ufd1-Npl4-mediated substrate unfolding and proteasomal degradation by positioning Ufd1 via a helix-UBX segment that tethers the UT3 ubiquitin-binding module of Ufd1 to the p97 N-domain; mutations abrogating the helix-Ufd1 interaction reduce stimulation of degradation.\",\n      \"method\": \"In vitro reconstitution of p97-Ufd1-Npl4-mediated unfolding coupled to proteasomal degradation, site-directed mutagenesis, biochemical unfolding assay\",\n      \"journal\": \"Science advances\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with purified components, mutagenesis, and mechanistic dissection of the helix-Ufd1 interaction\",\n      \"pmids\": [\"41790892\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"UBXD8 (FAF2) promotes mitochondrial fission by mediating DRP1 translocation to mitochondria; arsenic-induced upregulation of UBXD8 increases DRP1 phosphorylation and mitochondrial over-fission leading to apoptosis.\",\n      \"method\": \"siRNA knockdown of UBXD8, DRP1 translocation assay (fractionation/immunofluorescence), mitochondrial morphology assay, Mdivi-1 inhibitor rescue\",\n      \"journal\": \"Molecular neurobiology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — KD with mechanistic readout (DRP1 translocation), but single lab and toxicological context\",\n      \"pmids\": [\"39570499\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Polyserine-targeted FAF2/UBXD8 suppresses tau aggregation independent of VCP but requiring ubiquitination, membrane localization, and its UBX domain; delivery of targeted FAF2/UBXD8 reduces insoluble tau and gliosis in PS19 tau transgenic mice.\",\n      \"method\": \"Polyserine targeting in cell-based tau aggregation assays, domain deletion mutants (UBX, membrane-targeting), Drosophila tau neurodegeneration model, PS19 mouse model (behavioral and biochemical readouts)\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 — domain mutagenesis, in vivo animal validation in two model organisms, multiple orthogonal readouts\",\n      \"pmids\": [\"40902597\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2002,\n      \"finding\": \"ETEA (FAF2) protein interacts with the Fas death domain, albeit more weakly than FAF1, and is expressed in the cytoplasm; the ETEA-EGFP fusion protein localizes to the cytoplasm.\",\n      \"method\": \"Yeast two-hybrid, EGFP fusion localization\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — yeast two-hybrid and single localization experiment; no rigorous mechanistic follow-up\",\n      \"pmids\": [\"12372427\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"FAF2/UBXD8 is a multi-domain (UBA, UAS, UBX) membrane-embedded adaptor protein that recruits the AAA-ATPase p97/VCP to the ER, lipid droplets, mitochondria, and ER-mitochondria contact sites to drive ubiquitin-dependent substrate extraction and proteasomal degradation (ERAD substrates, HMGCR, ApoB, Noxa, Bnip3); its UAS domain acts as a direct sensor for long-chain unsaturated fatty acids that induce oligomerization and relieve inhibition of triglyceride synthesis; and its UBX domain, together with a helix segment that positions Ufd1 on p97, is required for stimulating p97-mediated substrate unfolding, proteasomal degradation, peroxisome quality control via suppression of pexophagy, mRNP disassembly, and neurofibromin ubiquitination.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"FAF2/UBXD8 is a membrane-embedded, multi-domain adaptor protein that recruits the AAA-ATPase p97/VCP to the ER, lipid droplets, mitochondria, ER-mitochondria contact sites, and peroxisomes, coupling ubiquitin-dependent substrate extraction to proteasomal degradation across multiple organellar quality-control pathways. Its UBA, UAS, and UBX domains enable recognition of ubiquitinated substrates and p97 engagement: the UAS domain directly senses long-chain unsaturated fatty acids, which induce its oligomerization and relieve FAF2-mediated inhibition of triglyceride synthesis, while a helix-UBX segment positions the Ufd1 cofactor on p97 to stimulate substrate unfolding and degradation [PMID:21115839, PMID:23720822, PMID:41790892]. FAF2 mediates sterol-induced HMGCR dislocation, lipidated ApoB-100 turnover on lipid droplets, degradation of pro-apoptotic BH3-only proteins at mitochondria, control of ER-mitochondria contact site extent via SREBP1/SCD1, suppression of pexophagy through regulation of peroxisomal membrane protein ubiquitination, and HuR release from mRNPs leading to mRNA destabilization [PMID:28882874, PMID:22238364, PMID:35979733, PMID:36746962, PMID:39929145, PMID:23618873]. On lipid droplets, FAF2 additionally inhibits ATGL-mediated lipolysis by directly binding ATGL and dissociating its coactivator CGI-58, with its ER-to-LD trafficking regulated by the rhomboid pseudoprotease UBAC2 [PMID:23297223].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Initial identification of FAF2 (ETEA) as a Fas-associated protein established it as a potential component of death-receptor signaling, though its functional role remained unclear.\",\n      \"evidence\": \"Yeast two-hybrid screen identifying interaction with the Fas death domain; EGFP fusion localization\",\n      \"pmids\": [\"12372427\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"Interaction with Fas not validated by reciprocal co-IP or in vitro binding\", \"No functional consequence of the Fas interaction demonstrated\", \"Cytoplasmic localization does not resolve membrane association\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Demonstration that FAF2 dynamically shuttles between the ER and nascent lipid droplets via lateral membrane diffusion established its dual-organelle residency and linked it to lipid droplet biogenesis.\",\n      \"evidence\": \"Live-cell fluorescence imaging with EGFP-FAF2, dominant-negative Sar1, protein synthesis inhibition in mammalian cells\",\n      \"pmids\": [\"19773358\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Membrane anchor topology not fully resolved\", \"Signal triggering ER-to-LD migration not identified at the molecular level\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Two studies revealed FAF2's dual biochemical activities: direct sensing of unsaturated fatty acids via conformational change and oligomerization that controls triglyceride synthesis, and UBX-domain-dependent ubiquitination and degradation of neurofibromin, establishing FAF2 as both a lipid sensor and a p97-dependent degradation adaptor.\",\n      \"evidence\": \"In vitro reconstitution with purified recombinant FAF2 (thermal stability, limited proteolysis, native PAGE oligomerization) plus siRNA knockdown for lipid synthesis; proteomics-identified neurofibromin interaction, in vitro ubiquitination assay, domain mutants with Ras activity readout\",\n      \"pmids\": [\"21115839\", \"20160012\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of the fatty acid binding site within the UAS domain not structurally resolved\", \"Whether neurofibromin ubiquitination is a direct E3 activity or requires a recruited E3 ligase\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Showing that FAF2 recruits p97 to lipid droplets for post-dislocation degradation of lipidated ApoB-100 defined it as the critical LD-localized adaptor for ERAD-like substrate processing outside the ER.\",\n      \"evidence\": \"siRNA knockdown of UBXD8, co-IP with Derlin-1 and ApoB, immunofluorescence of p97 recruitment to LDs\",\n      \"pmids\": [\"22238364\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether other UBX-domain proteins can substitute for FAF2 on LDs\", \"Structural basis of FAF2-Derlin-1 interaction unknown\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Multiple 2013 studies expanded FAF2's mechanistic repertoire: (1) UBAC2 was identified as an ER-resident factor restricting FAF2 LD trafficking; (2) FAF2 was shown to inhibit ATGL lipolysis by direct binding and CGI-58 displacement on LDs; (3) the UAS domain's positively charged surface was mapped as the UFA-sensing oligomerization interface; (4) the p97-FAF2 complex was linked to mRNP remodeling via K29-ubiquitin-dependent HuR release.\",\n      \"evidence\": \"Co-IP and live-cell imaging for UBAC2 interaction; in vitro binding assay of purified FAF2 to ATGL; UAS domain mutagenesis with native PAGE; RNA immunoprecipitation and ubiquitin linkage analysis for HuR/mRNA regulation\",\n      \"pmids\": [\"23297223\", \"23720822\", \"23618873\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural model of UAS-UFA complex lacking\", \"Mechanism by which K29-linked ubiquitin on HuR is generated not identified\", \"Whether UBAC2-mediated retention is regulated by metabolic cues\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"The finding that ALS-linked UBQLN2 mutations impair interaction with FAF2 and compromise ERAD connected FAF2 to neurodegenerative disease pathology.\",\n      \"evidence\": \"Co-IP of UBQLN2 and FAF2 in vitro and in vivo; ERAD substrate accumulation with mutant UBQLN2\",\n      \"pmids\": [\"24215460\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"UBQLN2-FAF2 interaction not validated by independent lab\", \"Whether FAF2 loss alone phenocopies UBQLN2-mutant ERAD defects not tested\", \"Structural basis of the UBQLN2-FAF2 interaction unknown\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Identification of FAF2 as essential for sterol-induced HMGCR degradation via an unbiased haploid genetic screen established it as a non-redundant component of cholesterol homeostasis, with the UBX domain required for membrane dislocation.\",\n      \"evidence\": \"CRISPR/Cas9 haploid screen, UBXD8 KO and rescue, UBX domain deletion, HMGCR dislocation assay in multiple cell types\",\n      \"pmids\": [\"28882874\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether FAF2 directly contacts HMGCR or acts via Insig/gp78 complex\", \"In vivo cholesterol phenotype in FAF2 knockout animals not reported\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Discovery of FAF2 localization to mitochondria and its role in degrading pro-apoptotic BH3-only proteins (Noxa, Bik, Bnip3) revealed it as a mitochondrial quality-control factor restraining apoptosis and mitophagy.\",\n      \"evidence\": \"Subcellular fractionation, co-IP with mitochondrial E3 ligases, UBXD8 KO with apoptosis and mitophagy phenotype, substrate ID by mass spectrometry\",\n      \"pmids\": [\"35979733\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How FAF2 is targeted to OMM versus ER versus LDs not resolved\", \"Which mitochondrial E3 ligase is the primary partner\"]\n    },\n    {\n      \"year\": 2023,\n      \"claim\": \"Localization of the p97-FAF2 complex to ER-mitochondria contact sites and demonstration that its loss increases ERMCS extent and elevates membrane lipid saturation via SREBP1/SCD1 identified FAF2 as a regulator of inter-organelle contact site homeostasis and lipid composition.\",\n      \"evidence\": \"Proximity ligation, quantitative proteomics and lipidomics of ERMCS fractions, UBXD8 KO, p97 inhibitor, SREBP1/SCD1 epistasis\",\n      \"pmids\": [\"36746962\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific ERMCS substrate(s) extracted by p97-FAF2 not identified\", \"Whether ERMCS regulation is direct or secondary to lipid composition changes\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Two studies established FAF2 as a suppressor of pexophagy by controlling ubiquitination of peroxisomal membrane proteins (PMP70/ABCD3), with UBX and UAS domains required for peroxisome homeostasis and protection against saturated fatty acid stress.\",\n      \"evidence\": \"Quantitative proteomics, FAF2 KO, pexophagy flux assay, ABCD3 ubiquitination assay, USP30 rescue, genome-wide CRISPR screen, domain deletion analysis\",\n      \"pmids\": [\"39929145\", \"40601736\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Which E3 ligase ubiquitinates ABCD3 under FAF2 control not identified\", \"Whether FAF2 localizes to peroxisomes directly or acts from ER\", \"Independent replication of peroxisome phenotype by additional labs needed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Engineering polyserine-targeted FAF2 to suppress tau aggregation in cell, fly, and mouse models demonstrated that FAF2's ubiquitin-dependent degradation machinery can be redirected to pathological protein aggregates, establishing therapeutic proof-of-concept.\",\n      \"evidence\": \"Polyserine targeting in tau aggregation assays, domain deletion mutants, Drosophila neurodegeneration model, PS19 mouse model with behavioral and biochemical readouts\",\n      \"pmids\": [\"40902597\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether endogenous FAF2 engages tau in unmodified settings unknown\", \"Long-term safety and off-target degradation not assessed\", \"Mechanism by which membrane-localized FAF2 accesses cytoplasmic tau aggregates unclear\"]\n    },\n    {\n      \"year\": 2026,\n      \"claim\": \"In vitro reconstitution revealed that FAF2 stimulates p97-Ufd1-Npl4-mediated substrate unfolding and proteasomal degradation by positioning Ufd1's UT3 ubiquitin-binding module on the p97 N-domain via a helix-UBX segment, resolving the long-standing question of how UBX-domain cofactors enhance p97 processivity.\",\n      \"evidence\": \"In vitro reconstitution of p97-mediated unfolding coupled to proteasomal degradation with purified components; site-directed mutagenesis of helix-Ufd1 interface\",\n      \"pmids\": [\"41790892\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether the helix-UBX mechanism is shared by FAF1 in vivo\", \"Structural resolution of the ternary FAF2-Ufd1-p97 complex lacking\", \"Contribution of UBA domain to substrate selection during unfolding not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions include: the structural basis for UAS domain fatty acid sensing and oligomerization; how FAF2 is differentially targeted to ER, lipid droplets, mitochondria, ERMCS, and peroxisomes; and whether FAF2 loss in vivo causes metabolic or neurological disease in mammals.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No high-resolution structure of full-length FAF2 or the UAS-UFA complex\", \"No animal knockout phenotype systematically characterized\", \"Mechanisms governing organelle-specific targeting of a single membrane-embedded adaptor unresolved\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [1, 3, 6, 8, 10, 11, 12, 13, 15]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"GO:0140299\", \"supporting_discovery_ids\": [4, 5]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [1, 9, 15]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [0, 2, 8]},\n      {\"term_id\": \"GO:0005811\", \"supporting_discovery_ids\": [1, 2, 3]},\n      {\"term_id\": \"GO:0005739\", \"supporting_discovery_ids\": [10, 16]},\n      {\"term_id\": \"GO:0005777\", \"supporting_discovery_ids\": [12, 13, 14]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [3, 8, 9, 10, 15]},\n      {\"term_id\": \"R-HSA-1430728\", \"supporting_discovery_ids\": [1, 4, 5, 8, 11]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [12, 13]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [10]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"complexes\": [\n      \"p97/VCP-Ufd1-Npl4 complex\"\n    ],\n    \"partners\": [\n      \"VCP\",\n      \"UFD1\",\n      \"UBAC2\",\n      \"ATGL\",\n      \"UBQLN2\",\n      \"NF1\",\n      \"ELAVL1\",\n      \"DRP1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}